Charles Schoch - Jul 17, 2024 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Interim Chief Financial Officer
Signature
/s/ Charles Schoch
Stock symbol
CADL
Transactions as of
Jul 17, 2024
Transactions value $
-$63,975
Form type
4
Date filed
7/19/2024, 08:28 AM
Previous filing
Jul 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Sale -$64K -9.88K -13.65% $6.47 62.5K Jul 17, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Remarks:

Interim Chief Financial Officer